Conventional small molecular chemical drugs always have challenging limitations in cancer therapy due to their high systemic toxicity and low therapeutic efficacy. Nanotechnology has been applied in drug delivery, bringing new promising potential to realize effective cancer treatment. In this context, we develop here a new nanomicellar drug delivery platform generated by amphiphilic phosphorus dendrons (1-C17G3.HCl), which could form micelles for effective encapsulation of a hydrophobic anticancer drug doxorubicin (DOX) with a high drug loading content (42.4%) and encapsulation efficiency (96.7%). Owing to the unique dendritic rigid structure and surface hydrophilic groups, large steady void space of micelles can be created for drug encapsulation. The created DOX-loaded micelles with a mean diameter of 26.3 nm have good colloidal stability. Strikingly, we show that the drug-free micelles possess good intrinsic anticancer activity and act collectively with DOX to take down breast cancer cells in vitro and the xenografted tumor model in vivo through upregulation of Bax, PTEN, and p53 proteins for enhanced cell apoptosis. Meanwhile, the resulting 1-C17G3.HCl@DOX micelles significantly abolish the toxicity relevant to the free drug. The findings of this study demonstrate a unique nanomicelle-based drug delivery system created with the self-assembling amphiphilic phosphorus dendrons that may be adapted for chemotherapy of different cancer types.
传统的小分子
化学药物在癌症治疗中总是存在挑战性的局限性,因为它们具有高全身毒性和低治疗效果。纳米技术已应用于药物输送,为有效治疗癌症带来了新的希望。在此背景下,我们开发了一种新的纳米胶束药物输送平台,由两性
磷树状分子(1-C17G3.HCl)产生,可形成微胞,有效包裹疏
水性抗癌药物
阿霉素(DOX),药物负载含量高(42.4%),包裹效率高达96.7%。由于独特的树状刚性结构和表面亲
水基团,微胞可形成较大的稳定空隙,用于药物包裹。所形成的平均直径为26.3 nm的载药微胞具有良好的胶体稳定性。值得注意的是,我们发现不含药物的微胞具有良好的内在抗癌活性,并与DOX共同作用,通过上调Bax、
PTEN和p53蛋白来增强细胞凋亡,从而在体外和体内异种移植肿瘤模型中杀死乳腺癌细胞。同时,所得的1-C17G3.HCl@DOX微胞显著消除了与游离药物相关的毒性。这项研究的结果表明,利用自组装两性
磷树状分子创建了一种独特的基于纳米胶束的药物输送系统,可用于不同癌症类型的化疗。